title: A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility.
abstract: OBJECTIVE
  Very early rehabilitation, with an emphasis on mobilization, may contribute to improved outcomes after stroke. We hypothesized that a very early rehabilitation protocol would be safe and feasible.
  
  
  METHODS
  We performed a randomized, controlled trial with blinded outcome assessment. Patients at <24 hours after stroke were recruited from 2 Melbourne metropolitan stroke units. Patients were randomly assigned to receive standard care (SC) or SC plus very early mobilization (VEM) until discharge or 14 days (whichever was sooner). The primary safety outcome was the number of deaths at 3 months. The primary feasibility outcome was a higher "dose" of mobilization achieved in VEM. Secondary safety outcomes included adverse events (including falls and early neurologic deterioration), compliance with physiologic monitoring criteria, and patient fatigue after interventions. Secondary feasibility outcomes included "contamination" of standard care.
  
  
  RESULTS
  Overall, 18% of patients screened were suitable for recruitment. Seventy-one patients were recruited and randomized, with 2 dropouts by 12 months. The majority experienced ischemic strokes (87%). The group mean+/-SD age was 74.7+/-12.5 years, and 58% (n=41) had a National Institutes of Health Stroke Scale score >7. There was no significant difference in the number of deaths between groups (SC, 3 of 33; VEM, 8 of 38; P=0.20). Almost all deaths occurred in patients with severe stroke. Secondary safety outcomes were similar between groups. The intervention protocol was successfully delivered, achieving VEM dose targets (double SC, P=0.003) and faster time to first mobilization (P<0.001).
  
  
  CONCLUSIONS
  VEM of patients within 24 hours of acute stroke appears safe and feasible. Intervention efficacy and cost-effectiveness are currently being tested in a large randomized, controlled trial.
authors.affiliation: National Stroke Research Institute, Level 1, Neurosciences Building, Heidelberg Repatriation Hospital, 300 Waterdale Rd, Heidelberg, 3081 Victoria, Australia. J.Bernhardt@unimelb.edu.au
authors.forename: Julie
authors.initials: J
authors.lastname: Bernhardt
authors.forename: Helen
authors.initials: H
authors.lastname: Dewey
authors.forename: Amanda
authors.initials: A
authors.lastname: Thrift
authors.forename: Janice
authors.initials: J
authors.lastname: Collier
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Donnan
mesh_terms: D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D002545:Brain Ischemia / Q000534:rehabilitation / Q000628:therapy; D004185:Disability Evaluation; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D026741:Physical Therapy Modalities / Q000009:adverse effects; D020521:Stroke / Q000628:therapy*; D000071939:Stroke Rehabilitation; D013997:Time Factors; D016138:Walking